Medima Pharmaceuticals LLP

Medima Pharmaceuticals LLP - business services in New Delhi, Delhi, India. Directors, charges & compliance details.
LLPIN ACK-0531 Incorporated 22 October 2024 ROC Delhi HQ New Delhi, Delhi, India
Active Limited Liability Partnership
Contribution obligation
₹10,000
As per LLP agreement
LLP age
2 yrs
Est. 2024
Designated partners
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
LLP status
Active
MCA master data
Registrar
Delhi
ROC office
Incorporated
22 Oct 2024
Date of incorporation
Entity type
LLP
As registered with MCA

About Medima Pharmaceuticals LLP

Data last updated:

Medima Pharmaceuticals LLP is a limited liability partnership (LLP) based in New Delhi, Delhi, India. It was incorporated on 22 October 2024.

The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN ACK-0531.

The LLP has a total obligation of contribution of β‚Ή10,000. It is led by designated partners Pooja Raj and Kailash.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at 9/109 F/F Dakshin Puri Extention, Near Birat Cinema, New Delhi, Delhi, India – 110062.

Company details

LLPIN ACK-0531
Incorporation Date 22 October 2024
Total Obligation of Contribution β‚Ή10,000
ROC Delhi
Company Status Active

Contact details

Medima Pharmaceuticals LLP's registered office is in New Delhi, Delhi.

  • Registered Address
    9/109 F/F Dakshin Puri Extention, Near Birat Cinema, New Delhi, Delhi, India – 110062
Comprehensive company report
Medima Pharmaceuticals LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout Β· GST invoice included

Financials of Medima Pharmaceuticals LLP

FY 2025 filings available

Financial Statement Summary

Statement of Account and SolvencyFY 2024-25
Income and Expenditure
Turnover
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2024-25
Profitability
Net Profit Margin
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Medima Pharmaceuticals LLP, buy the company report.

Designated partners of Medima Pharmaceuticals LLP

Medima Pharmaceuticals has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Pooja RajDesignated Partner22 Oct 20242 Years 0 MonthsCurrent
KailashDesignated Partner25 Sep 20251 Years 1 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Medima Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Medima Pharmaceuticals LLP; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Medima Pharmaceuticals LLP has 3 designated partner changes on record since 2024: 3 appointments. The latest: Kailash was appointed as Designated Partner on 25 Sep 2025.

Appointed
Kailash was appointed as Designated Partner.
AGM
Medima Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Medima Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Payal Raj was appointed as Designated Partner.
Appointed
Pooja Raj was appointed as Designated Partner.
Incorporation
22 Oct 2024
Medima Pharmaceuticals Llp was registered on 22 Oct 2024 with Roc Delhi & aged 2 years 27 days as per MCA records.

Frequently asked questions

Medima Pharmaceuticals is an active limited liability partnership based in New Delhi, Delhi, India. It was incorporated on 22 October 2024 (2+ years old) and is registered under LLPIN ACK-0531.

Medima Pharmaceuticals has 2 current designated partners:

The latest financial statements of Medima Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2025 are in the company report.

The LLPIN (Limited Liability Partnership Identification Number) of Medima Pharmaceuticals is ACK-0531. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Medima Pharmaceuticals was incorporated on 22 October 2024, making it 2+ years old. It is registered with the Registrar of Companies, Delhi.

Kailash was appointed as Designated Partner on 25 Sep 2025. Payal Raj was appointed as Designated Partner on 22 Oct 2024. Pooja Raj was appointed as Designated Partner on 22 Oct 2024.

The registered office of Medima Pharmaceuticals is at 9109 FF Dakshin Puri Extention, Near Birat Cinema, New Delhi, Delhi, India – 110062.

Medima Pharmaceuticals can be reached at its registered office: 9109 FF Dakshin Puri Extention, Near Birat Cinema, New Delhi, Delhi, India – 110062.

Medima Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.